Microport mainly engages in medical research and medical equipment production.
MicroPort, established in 1998, is a medical device manufacturer. The company's products cover ten major fields, such as implants, orthopedic medical devices, aortic and puncture vascular intervention products, electrophysiological medical devices and nerve implant products. Founded by Chang Yaohua, it went public on the Hong Kong Stock Exchange. The shareholders are Otsuka, Maxwell Maxcare Science, Shanghai ZJ Hi-Tech Investment, Starwick Investments. Microport's direct competitors include Lepu Medical and Weigao.
ResearchTechnology, Consumer Staples, Healthcare
WIA2020 | Rising Tech Stars 2020: Global & China's 100
Sinopharm COVID Vaccine Receives WHO Emergency Use Certification
The Sinopharm Group’s COVID Vaccine is the sixth vaccine to receive safety, efficacy and quality verification from the World Health Organization (WHO). It is the first vaccine from a non-Western country to receive WHO certification.
May 11, 2021 03:35 AM
Yunnan Baiyao's Revenue Rises 33%; Net Profit Falls 40% in 1Q 2021
On April 27, Yunnan Baiyao released a report for the first quarter of 2021 showing that the company's total operating revenue for the first quarter was 10.33 billion yuan, up 33.4% year-on-year; its operating profit was 880 million yuan, down 41.8% year-on-year; its net profit attributable to shareholders of the listed company was 760 million yuan.
Apr 30, 2021 02:07 AM